Radcliffe Cardiology

Guidelines provide the evidence. Live cases show how it translates into practice. Register free for RIO USA: ow.ly/X9xQ5102aQg 🗓️ 14–15 November 2026. Join leading electrophysiology experts for two days of live procedures, clinical discussion and practical education tailored to US practice. See how experienced operators approach clinical challenges, evaluate treatment options and make decisions during real-world cases. Led by Course Directors Devi Nair, Roderick Tung, Bradley Knight and Suneet Mittal RIO USA explores the latest advances in electrophysiology and cardiac rhythm management, delivering practical insights to support clinical decision-making. #RIOCongress #EPeeps

Spotlight On: Practice-Changing Lipid-Lowering Data Prof Chris Packard and Prof Philippe Gabriel Steg explore residual cardiovascular risk, triglyceride-rich lipoproteins and the evidence behind long-term cardiovascular benefit. Watch on demand: radc.life/xzUeWtLw #ESC2026 #Cardiology #LipidManagement This programme is supported by an unrestricted educational grant from Amarin.

In AF, reducing stroke risk is only part of the equation. How should clinicians balance protection against bleeding risk and treatment burden? This #WorldStrokeDay, Radcliffe Cardiology explores where new evidence is challenging established approaches to stroke prevention ▶️ CHAMPION-AF: Dr @VivekReddyMD & @Drdevignair discuss the trade-off between ischaemic events and bleeding Watch the full discussion: radc.life/tZ5KcGwS 📖 Can OAC safely be discontinued after successful AF ablation? radc.life/gOM1aAwY 🔬 What happens >10 years after PFO closure? radc.life/4nVDqysL How precisely can we prevent stroke while balancing the risks and burdens of treatment? #WorldStrokeDay #StrokePrevention

16% fewer unnecessary invasive coronary angiograms. 12% reduction in downstream non-invasive tests and 9% increase in PCI revascularisations. Dr Tim Fairbairn explores what the FISH & CHIPS findings reveal about Heartflow FFRct and coronary artery disease assessment. 🔗 Watch now: ow.ly/xhja5101OKm This series is supported by @Heartflow #FFRct #CardiacCT #MedTech #Cardiology #NHSInnovation #NHSTrusts

📚 New #ICRJournal Article: "Cardiogenic Shock Centres" 📚 Just Published! 🔓Access it here 👉 ow.ly/NchE106HrmF @ncurzen

🔴 Expert-led #CardioOnc webinar happening TODAY titled 'Is Cancer Still a Contraindication? Advanced Cardiac Procedures in Oncology Patients' 👉 radcliffecardiology.com/webi… ⏰ 13:00 GMT | 9:00 EDT Don’t miss out on this discussion with Dr Joe Carver, Dr Efstathia (Effie) Andrikopoulou, Prof Zaza Iakobishvili, Dr Inbar Nardi Agmon and Prof Dan Gilon. See you there 👋 This webinar is supported by IC-OS. @ICOSociety

Could CCTA provide what we need to plan and guide PCI? P4 compares CCTA-guided with IVUS-guided PCI, asking how far coronary CT could move beyond diagnosis 💬 Where could you rely on CCTA, and where would you still want IVUS? ▶️ Follow Radcliffe Cardiology for more expert perspectives from #TCT2026: radc.life/XdlUca8c @drnvanmieghem #TCT2026 #CCTA #PCI #IVUS

When is the right time to refer a patient for advanced HF evaluation? Following the ESC HF 2026 guideline updates, Prof Maja Cikes, Assoc. Prof. Oscar Braun and Prof. Gloria Färber discuss earlier referral pathways, LVAD therapy’s Class I recommendation, and the role of multidisciplinary decision-making. 🔗 Watch now: ow.ly/GIHo5101MhK #HeartFailure #LVAD #AdvancedHeartFailure #Cardiology #ESCGuidelines

🫀 Get practical guidance on diagnosing and managing #Hypertriglyceridemia with Dr Ashish Sarraju! 📺 @WomenAs1 #CLIMB2026 presents ASCVD Prevention & Lipid Management. 🔎 Explore lifestyle and secondary causes 💊 Review therapies for severe hypertriglyceridemia 🧬 Discover emerging approaches including apoC-III inhibition and gene editing 🔗 Watch here: ow.ly/BhW45101ECk #CardioEd #Lipidology #ASCVD

Can targeting apoC-III change how we define success in severe hypertriglyceridaemia? Explore the latest SHASTA-3 and SHASTA-4 data with Dr Robert Rosenson and Dr Erin Michos, including insights into triglyceride reduction and acute pancreatitis prevention. Watch on demand: radc.life/9nJhleun This programme is supported by an unrestricted educational grant from Arrowhead Pharmaceuticals. #ESC2026 #LipidManagement #Cardiology

Could drug-coated balloons change how we approach de novo coronary lesions? Ahead of #TCT2026, TRANSFORM II compares a sirolimus-coated balloon strategy with everolimus-eluting stenting 💬 Which patients could avoid a metallic scaffold, and when might stenting remain preferred? ▶️ Follow Radcliffe Cardiology for more expert perspectives from #TCT2026: radc.life/I9OTCeYX @drnvanmieghem #PCI #DrugCoatedBalloon

Heading to #TCT2026? Discover 4D ICE for LAAO and tricuspid workflows with hands-on training on November 1st. Get hands-on experience with the NUVISION™ Ultrasound Catheter, GE HealthCare Vivid™ Pioneer and HOTWIRE™ Transseptal Access System. ⏰ November 1st, 2:00–3:30 PM and 4:00–5:30 PM 📍Training Pavilion T51, Sails Pavilion, Upper Level Sponsored by GE HealthCare.

📚 New #USCJournal Article: "Multimodal Imaging in Coronary Artery Anomalies" 📚 Just Published! 🔓Access it here 👉 ow.ly/4eRg106Hnh9 @BrunoLimaMDPhD @CardioNerds #CVImaging #MedEd

What could PROGRESS mean for moderate aortic stenosis? With ~750 patients enrolled, the study compares TAVR with optimal medical therapy Ahead of #TCT2026, Prof @drnvanmieghem and Dr @kameloot3 consider what the data could tell us about TAVR vs medical therapy, and which patients might benefit ▶️ Follow Radcliffe Cardiology for more: radc.life/4hGlKJDB #TAVR #TCT2026

▶️ 'Real-World Experience: Minimizing Fluoroscopy With the Affera™ Mapping and Ablation System' with Dr Joshua Silverstein and Dr Amit Thosani is available to watch on demand 🔗ow.ly/HHJ250ZZhkI By watching, you will: • Understand the clinical and real-world safety data of the Affera mapping and ablation system and Sphere-9 catheter • Discuss clinician’s experience with workflow, safety and efficacy with the Affera mapping and ablation system and Sphere-9 catheter #Cardioloy #Epeeps #Electrophysiology

📚 New #ICRJournal Article: "Surgery for Aortic Regurgitation" 📚 Just Published! 🔓Access it here 👉 ow.ly/3OtM106HiQH #VascularDisease #MedEd

🚨 New #CardioOnc Webinar | 'Is Cancer Still a Contraindication? Advanced Cardiac Procedures in Oncology Patients' this Thursday. ⏰ 13:00 GMT | 09:00 EDT Don’t miss out on this discussion with Dr Joe Carver, Dr Efstathia (Effie) Andrikopoulou, Prof Zaza Iakobishvili, Dr Inbar Nardi Agmon and Prof Dan Gilon. Register now👉 radcliffecardiology.com/webi… This webinar is supported by IC-OS.

“My most depressing clinic is now my most exciting.” Once untreatable. Now treatable. But only if we diagnose it. This #WorldAmyloidosisDay, know what you're looking for, #ThinkAmyloidosis. From Diagnosis to Care: ATTR Amyloidosis, the very first Radcliffe documentary, coming soon. Supported by an unrestricted educational grant from AstraZeneca and Ultromics. This content is intended for healthcare professionals only. #radcliffedocumentaries #fromdiagnosistocare

Can we really separate metabolic health from cardiovascular risk? Ahead of #AHA2026, this VITAL Initiative roundtable explores the links between visceral adiposity, liver health, dysglycaemia and cardiovascular disease. 3 Nov 2026 | 13:00 ET | 19:00 CET | Faculty: Dr Sarah Jarvis (@DrSarahJarvis) Dr Biykem Bozkurt (@BiykemB) Dr Pam Taub (@PamTaubMD) and Prof Carel Le Roux (@carel_leroux) Register free 🔗radc.life/Pr9nYs7h This programme has been sponsored by Boehringer Ingelheim. #VITALmetabolic #CardiometabolicHealth #Obesity #LiverHealth